The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine. (Q44587821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

Ligilactobacillus salivarius

5 February 2020

main subject

object named as

Lactobacillus salivarius

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Natividad Garrido-Mesa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ian R Sanderson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

María Elena Rodríguez-Cabezas

5 February 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

6

Elvira Bailón

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

11

Antonio Zarzuelo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

8

Jordi Xaus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

5

Mònica Comalada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

7

Mónica Olivares

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

4

Desirée Camuesco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1

Belén Arribas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Laura Perán

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Laurens Kruidenier

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

1 reference

19 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nutrition

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

365-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

The mechanism of action of probiotics

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

The impact of probiotic on gut health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Antimicrobial potential of four Lactobacillus strains isolated from breast milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

The immunology of mucosal models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Variable response to probiotics in two models of experimental colitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Innate immunity in inflammatory bowel disease: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Alleviation of Experimental Septic Shock in Mice by Acidic Polysaccharide Isolated from the Medicinal Mushroom Phellinus linteus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-011-0221-4

Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response

21 January 2018

1 reference

12 December 2020

Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models

1 reference

12 December 2020

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Lactobacillus GG bacteria ameliorate arthritis in Lewis rats

1 reference

12 December 2020

Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.

1 reference

12 December 2020

1 reference

12 December 2020

Effect of probiotic Lactobacillus strains in children with atopic dermatitis

1 reference

12 December 2020

Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma

1 reference

12 December 2020

Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions

1 reference

12 December 2020

Determination of glutathione and glutathione disulfide in biological samples

1 reference

12 December 2020

10.1007/S00394-011-0221-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21688122%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference